Ying Li

机构：Macau University of Science and Technology, Tianjin University of Traditional Chinese Medicine, Henan University of Science and Technology, Yangtze University, Chinese Academy of Medical Sciences & Peking Union Medical College, Xiyuan Hospital, First Affiliated Hospital of Henan University of Science and Technology, First Affiliated Hospital of Henan University, Hubei University of Technology · ORCID：0000-0002-0325-7886

发表论文 149 篇 · 总被引 1924 次 · h-index 24

代表论文

• Ginsenoside Rh1 Improves Type 2 Diabetic Nephropathy through AMPK/PI3K/Akt-Mediated Inflammation and Apoptosis Signaling Pathway (2021 · The American Journal of Chinese Medicine · 被引 58)
• Effect of Tetramethylpyrazine on Neuroplasticity after Transient Focal Cerebral Ischemia Reperfusion in Rats (2021 · Evidence-based Complementary and Alternative Medicine · 被引 22)
• The regulation of miRNAs using curcumin and other polyphenols during the prevention and treatment of Alzheimer’s disease (2024 · Human Molecular Genetics · 被引 12)
• Medicinal Potential of Broussonetia papyrifera: Chemical Composition and Biological Activity Analysis (2025 · Plants · 被引 11)
• Ultrasound-assisted dispersive solid phase extraction for promoting enrichment of ng L−1 level Hg2+ on ionic liquid coated magnetic materials (2021 · Analytica Chimica Acta · 被引 10)
• AviTag-nanobody based enzyme immunoassays for sensitive determination of aflatoxin B1 in cereal (2024 · LWT · 被引 9)